We are live on ! Find out more
VHAQ.WS

Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share
VHAQ.WS

Delisted

VHAQ.WS was delisted on the 23rd of October, 2023.

31 hedge funds and large institutions have $9.9M invested in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% more capital invested

Capital invested by funds: $9.37M → $9.9M (+$539K)

6% less funds holding

Funds holding: 3331 (-2)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
31
Holders Change
-2
Holders Change %
-6.06%
% of All Funds
0.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
3
Reduced
4
Closed
3
Calls
$2.49M
Puts
Net Calls
+$2.49M
Net Calls Change
+$28K
Name Holding Trade Value Shares
Change
Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
$2K +$99 +1,401 +9%
OMC
27
Old Mission Capital
Illinois
$2K +$279 +3,953 +30%
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$2K +$772 +10,940 +72%
WAM
29
Wolverine Asset Management
Illinois
$1K
SCM
30
Saba Capital Management
New York
$1K +$1.09K +15,399 New
ICMH
31
Integrity Capital Management (HK)
Hong Kong
-$1K -27,066 Closed
VF
32
Virtu Financial
New York
-$1K -13,863 Closed
UBS Group
33
UBS Group
Switzerland
-$7 -100 -2%

VHAQ.WS Hedge Fund Activity: Q3 2022 in Review

31 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) for Q3 2022, worth a combined $9.9M — up 5.8% from $9.37M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of VHAQ.WS and 1 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 3 added.

The largest buyer was Saba Capital Management, opening a new position worth an estimated $1.09K. The largest seller was Picton Mahoney Asset Management, cutting an estimated $12.6K.

  • 31 institutional investors held Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) as of Q3 2022, down from 33 in Q2 2022.
  • Funds reported $9.9M of Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share stock for Q3 2022, up 5.8% quarter-over-quarter.
  • 1 fund opened new Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share positions in Q3 2022 and 3 closed out, a net change of -2 holders.
  • The largest Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share buyer in Q3 2022 was Saba Capital Management, an estimated $1.09K added.
  • The largest Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share seller in Q3 2022 was Picton Mahoney Asset Management, an estimated $12.6K sold.

Based on aggregated 13F filings for Q3 2022.